US Stock MarketDetailed Quotes

TRDA Entrada Therapeutics

Watchlist
  • 14.100
  • -0.260-1.81%
Trading May 10 11:23 ET
476.00MMarket Cap20.43P/E (TTM)

Entrada Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Entrada Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

59.12M

+134.05%
EPS(YoY)

0.68

+423.81%
Analyst Rating

Buy

Apr 30, 2024

Entrada Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 24.500M--
--2024/Q2-- / 36.075M--
--2024/Q159.120M / 15.195M--
--2023/Q441.848M / 23.695M--
--2023/Q343.735M / 9.598M--
--2023/Q218.170M / 9.776M--
--2023/Q125.260M / 79.333M--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 24.500M--
--2024/Q2-- / 36.075M--
--2024/Q159.120M / 15.195M--
--2023/Q441.848M / 23.695M--
--2023/Q343.735M / 9.598M--
--2023/Q218.170M / 9.776M--
--2023/Q125.260M / 79.333M--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Entrada Therapeutics Earnings Reports

  • Entrada Therapeutics | 10-Q: Quarterly report

    May 7 19:14

  • Entrada Therapeutics | 10-K: Annual report

    Mar 13 19:28

  • Entrada Therapeutics: Q3 2023 Earnings Report

    Nov 7, 2023 20:20

  • Entrada Therapeutics | 10-Q/A: Quarterly report (Amendment)

    Aug 8, 2023 19:25

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg